publish.UP Relaxin-2 does not Ameliorate Nephropathy in an...
publishup.uni-potsdam.de
Metadaten; Author: Thomas Bernd Dschietzig, Katharina Krause-Relle, Maud Hennequin, Karoline von Websk, Jan Rahnenfuhrer, Jana …
Relaxin and Related Peptides von O. David Sherwood | ISBN...
www.lehmanns.de
The Pregnancy Hormone Relaxin Binds to and Activates the Human Glucocorticoid Receptor: Thomas Dschietzig, Cornelia Bartsch, Michael Greinwald, Gert ...
Relaxin, a pleiotropic vasodilator for the treatment of heart failure
www.proquest.com
von SL Teichman · · Zitiert von: 152 — Sam L. Teichman Æ Elaine Unemori Æ Thomas Dschietzig Æ. Kirk Conrad Æ Adriaan A. Voors Æ John R. Teerlink Æ. G. Michael Felker Æ Marco Metra Æ Gad Cotter. › openview › 1.pdf
Summary of the proposed relaxin signaling during lung IR.
core.ac.uk
— Konstantin Alexiou ( ) · Manuel Wilbring ( ) · Klaus Matschke ( ) · Thomas Dschietzig ( ). Publication date: › display
Relaxin, a pleiotropic vasodilator for the treatment of BioMedSearchwww.biomedsearch.com _2008_Article_9129.pdf
www.biomedsearch.com
Sam L. Teichman Æ Elaine Unemori Æ Thomas Dschietzig Æ. Kirk Conrad Æ Adriaan A. Voors Æ John R. Teerlink Æ. G. Michael Felker Æ ...
Alle Infos zum Namen "Thomas Dschietzig"
Relaxin-2 Does Not Ameliorate Nephropathy in an Experimental Model of...
bib.vetmed.fu-berlin.de
Relaxin-2 Does Not Ameliorate Nephropathy in an Experimental Model of Type-1 Diabetes ... Autoren Dschietzig, Thomas Bernd Krause-Relle, Katharina Hennequin, Maud (WE 2)
Clinical trial: Recombinant Human Relaxin for the Treatment of...
www.druglib.com
Clinical trial: Recombinant Human Relaxin for the Treatment of Decompensated CHF
Recombinant Human Relaxin for the Treatment of Decompensated CHF -...
clinicaltrials.gov
Principal Investigator: Thomas Dschietzig, MD, Charite Hospital, Berlin, Germany. More Information. Go to sections. Top of Page Study Description Study ... › show › N...
Relaxin family peptide receptors in GtoPdb v |...
journals.ed.ac.uk
von R Bathgate · — Thomas Dschietzig Charité-University Medicine Berlin · Andrew L. Gundlach University of Melbourne ... › view
Relaxin, via PI3K, phosphorylates FKHRL Figshare
figshare.com
posted on , 19:11 by Konstantin Alexiou, Manuel Wilbring, Klaus Matschke, Thomas Dschietzig. Isolated rat lungs perfused with buffer in — Lyubov Chaykovska · Fabian Heunisch · Gina von Einem · Markus L. Alter · Carl-Friedrich Hocher · Oleg Tsuprykov · Thomas Dschietzig · Axel Kretschmer ... › articles › figure › articles › figure ›
Altmetric – Relaxin improves TNF-α-induced endothelial dysfunction:...
oxfordjournals.altmetric.com
DOI, cvr/cvs149. Pubmed ID Authors. Thomas Dschietzig, Anna Brecht, Cornelia Bartsch, Gert Baumann, Karl Stangl, Konstantin Alexiou ...
Relaxin, a pleiotropic vasodilator for the treatment of heart...
research.rug.nl
author = "Teichman, {Sam L.} and Elaine Unemori and Thomas Dschietzig and Kirk Conrad and Voors, {Adriaan A.} and Teerlink, {John R.} and Felker, {G.
Relaxin-2 bei diabetischer Nephropathie
forschungsberichte.charite.de
Univ. Prof. Dr. Verena Stangl, PD DR. Thomas Dschietzig
eNOS-iNOS cross-talk: relaxin-related stimulation of iNOS is mediated...
figshare.com
posted on , 02:11 by Konstantin Alexiou Manuel Wilbring Klaus Matschke Thomas Dschietzig. Isolated rat lungs perfused with buffer in recirculatory ...
PLOS ONE: Relaxin
journals.plos.org
... from Ischemia-Reperfusion Injury via Inducible NO Synthase: Role of ERK-1/2, PI3K, and... Konstantin Alexiou, Manuel Wilbring, [...], Thomas Dschietzig.
RELAXIN FOR TREATING PATIENTS AFFLICTED OF IMPAIRED GLUCOSE TOLERANCE...
www.patentsencyclopedia.com
... map information provided by MapQuest, OpenStreetMap and contributors, CC-BY-SA. Patent applications by Thomas Dschietzig, Berlin DE.
Relaxin Program version The 5 th International Conference...
businessdocbox.com
11:25 AM (25min) Thomas Dschietzig, Dept. of Cardiology & Angiology, Charité :15 AM (25min) Dennis Stewart, Corthera Inc. (BAS Medical Inc.) USA Scar ...
Relaxin Protects Rat Lungs from Ischemia-Reperfusion Injury via...
journals.plos.org
Competing interests: Thomas Dschietzig is employee of Immundiagnostik which holds a patent (DE A1) on “Relaxin in solutions ...
About: Recombinant Human Relaxin for the Treatment of Decompensated...
bio2rdf.org
lead sponsor [clin...ary:lead-sponsor] · Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies ... Thomas Dschietzig, MD ...
Verwandte Suchanfragen zu Thomas Dschietzig
Manuel Wilbring Klaus Matschke Oleg Tsuprykov | Axel Kretschmer Berthold Hocher Cornelia Bartsch | Volker Düsterhöft Gert Baumann Fabian Heunisch |
Personen Vorname "Thomas" (124868) Name "Dschietzig" (13) |
sortiert nach Relevanz / Datum